Malvinder Mohan Singh is the Chairman, CEO and of Ranbaxy Laboratories Ltd. (Ranbaxy). His company targets a sales target of US $5 Bn, by 2012. He has played a pivotal role in the company’s management and global operations. He finished his graduation in Economics from St. Stephen’s college, New Delhi, India. He took a Masters Degree course in Business Administration (MBA) from the Fuqua School of Business, Duke University, USA. He had earlier worked as President, Pharmaceuticals and Executive Director at Ranbaxy, handling the global operations covering Pharmaceuticals, API and Manufacturing spread across 49 countries. He also led the company’s India operations as Regional Director. He has expertise in diversified fields of General Management, Sales & Marketing, Finance and Business Development. He is a member of the National Council for the Confederation of Indian Industries (CII). He is also the Co- Chairman of the National committee on Intellectual Property Rights (IPR), CII. Recently, he was nominated to the prestigious forum of insightful, innovative and energetic ‘Young Global Leaders’, World Economic Forum.
